A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
about
Atypicality of atypical antipsychotics.Psychometric performance of an assessment scale for strain in nursing care: the M-NCASPrevalence of physical and verbal aggressive behaviours and associated factors among older adults in long-term care facilities.The BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical reviewThe long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's diseaseOptimal treatment of Alzheimer's disease psychosis: challenges and solutions.Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.Consequences from use of reminiscence--a randomised intervention study in ten Danish nursing homes.Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study.Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trialA systematic mapping review of randomized controlled trials (RCTs) in care homesPharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units.Approach to managing behavioural disturbances in dementia.Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial.The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design.Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysisAntipsychotic drugs and risks of myocardial infarction: a self-controlled case series studyThe development and testing of the quality use of medications in dementia (QUM-D): a tool for quality prescribing for behavioral and psychological symptoms of dementia (BPSD).Relapse risk after discontinuation of risperidone in Alzheimer's disease.Sedation mediates part of Citalopram's effect on agitation in Alzheimer's disease.Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function.ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.Risperidone and the treatment of psychiatric, motor, and cognitive symptoms in Huntington's disease.Current therapeutic options for Alzheimer's diseaseAtypical antipsychotics to treat the neuropsychiatric symptoms of dementia.Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.Management of psychosis in patients with Alzheimer's disease: focus on aripiprazole.Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD)Behavioral and psychological symptoms of dementia and their management.Antipsychotics, cognitive decline and death in Alzheimer's disease: the London and South-East Region Alzheimer's Disease longitudinal studyCSM warning on atypical psychotics and stroke may be detrimental for dementia.Efficacy and safety of brand-risperidone versus similar-risperidone in elderly patients with neuropsychiatric disorders: A retrospective study.French version of the Rating Scale for aggressive behaviour in the Elderly (F-RAGE): psychometric properties and diagnostic accuracy.Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.Pharmacological treatments for alleviating agitation in dementia: A systematic review and network meta-analysis.
P2860
Q24535908-61B7DE70-34F6-48FB-BFB9-93164F8B7FA4Q24801710-65053D81-3F1A-45D0-8FBA-F084FBA22253Q24816181-206F9211-C740-4CAD-944A-CC3C44BE929DQ27022753-5A3003C2-9D86-4E9C-9FBA-66E927D93D0AQ30413790-7FAE9F66-FB76-489F-9B1D-9805F2318466Q30423717-A4B56A1F-87C4-4BDF-A465-03260CCF65C2Q33203719-10058B85-66B7-47E2-B371-19CAA290259DQ33248004-7391F346-D906-4E86-BFBC-662E4ABB4814Q33595407-784E1BB1-AEB0-477F-B3AB-AEE4D4D615DBQ33869831-DC988BB6-B0CD-44AC-973E-AB2F4B355117Q33935882-B88499FA-B244-4F07-B6E1-CB9F77A58C6CQ34302047-890890C9-27C4-4609-A1AA-1D75727856CAQ34316513-633728C4-A8EF-4CC8-A79D-7DC43D9C377AQ34452896-1C94770F-07A4-4F54-B4E5-D5863AFC4893Q34580523-11040CF1-1B28-4F2E-A106-0F492862636CQ34683770-D90FEC7E-8C06-43FC-946B-BA1FF60803CAQ35109857-A1165C9E-752C-41B4-A7A9-8687B961F822Q35136544-55981AC1-7E45-4E16-B8F0-05F1F3664684Q35499945-170B8DA4-CD65-43AD-BBA8-56F64172BA3BQ35502460-49DA88E4-C717-4179-BF82-70B0956E7F7EQ35848943-86D7A89D-ED73-4396-8B1B-6C953077BF6DQ36375421-8D5451F8-B513-44CA-8AF8-949DA6BAA259Q36553622-AEB21647-4B53-4BC5-816D-8B2094CE66F7Q36710267-B658E8F1-F672-4E4A-A6F1-589F426EA3DCQ36885358-C5C991D5-DA03-4EFA-8F8F-DA24B88D0F9EQ37093708-51F5D15C-D6DF-4F60-834F-3C6FF8227389Q37108146-3896B90F-D6BD-4366-82E3-B77C1D6CE705Q37166113-BA744B0B-DA5E-4BB5-98A6-A98BC03BECB2Q37169607-713582CF-FD33-46F4-868A-3EA0D0E99788Q37316813-DB0E6F50-BBE0-4658-A7FB-3E8578CBDA5AQ37420475-35FC59D8-8859-44E1-8157-1D0C2E0F04DFQ37854476-6D4E6C48-63C1-4756-BD83-F8DF686DEF38Q42584578-1C3F0423-317D-4C33-A5C5-10D0EF07C3E2Q43241036-4C38F20F-39B5-4B9A-AA08-C8C62FBFE19BQ47137102-7DACF149-FC90-4644-B733-9C7BDFAEC732Q47161212-2FEBAB90-289A-41C7-A6E9-91A4ADDFA8A9Q47555313-4DAC2D08-A6A4-427B-8B98-5912F94ABE40Q53279360-8F49AFC9-8976-465E-8A71-6E6C84513D2B
P2860
A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A randomized placebo-controlle ...... on, and psychosis of dementia.
@en
A randomized placebo-controlle ...... on, and psychosis of dementia.
@nl
type
label
A randomized placebo-controlle ...... on, and psychosis of dementia.
@en
A randomized placebo-controlle ...... on, and psychosis of dementia.
@nl
prefLabel
A randomized placebo-controlle ...... on, and psychosis of dementia.
@en
A randomized placebo-controlle ...... on, and psychosis of dementia.
@nl
P2093
P356
P1476
A randomized placebo-controlle ...... ion, and psychosis of dementia
@en
P2093
David Ames
Fred Grossman
Henry Brodaty
Jeff Kirwan
John Snowdon
Michael Woodward
Roger Clarnette
P304
P356
10.4088/JCP.V64N0205
P577
2003-02-01T00:00:00Z